| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |